Madrigal Pharmaceuticals Inc (MDGL)

Cost of Revenue

$40.01M

Quarterly · Period ending: · USD

MDGL logo

MDGL Cost of Revenue

Latest reported$40.01M
MDGL Quarterly Cost of Revenue ($0.00 → $40.01M)
High-resolution chart · PNG

MDGL cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Madrigal Pharmaceuticals Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
40,007,000
26,847,000
24,448,000
18,122,000
9,065,000
4,513,000
3,445,000
2,152,000
636,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28,000
28,000
28,000
25,000
24,000
24,000
23,000
60,000
9,000
8,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
130,405,000
0
0
1,969,000
0
1,969,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.